Enhancement of isoleucine hydroxamate-mediated growth inhibition and improvement of isoleucine-producing strains of Serratia marcescens.
Growth inhibition by isoleucine hydroxamate in Serratia marcescens was significantly enhanced by adding valine plus leucine and by using glycerol as the carbon source. Isoleucine hydroxamate-resistant mutants were isolated under conditions in which growth inhibition was enhanced. One of the mutants, strain GIHVLr2179, lacked both feedback inhibition and repression of threonine deaminase. An alpha-aminobutyric acid-resistant mutant derived from strain GIHVLr2179, strain GIHVLAr2795, produced 12 mg of isoleucine per ml in the medium containing glucose and urea as carbon and nitrogen sources (a twofold increase over prior reports). This strain had increased activities of threonine deaminase, acetohydroxy acid synthase, aspartokinase, and homoserine dehydrogenase.
D000095:Acetolactate Synthase / Q000378:metabolism; D001222:Aspartate Kinase / Q000378:metabolism; D002474:Cell-Free System; D004794:Enzyme Repression; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D006715:Homoserine Dehydrogenase / Q000378:metabolism; D007532:Isoleucine / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000494:pharmacology; D007930:Leucine / Q000494:pharmacology; D009154:Mutation; D012706:Serratia marcescens / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D013913:Threonine Dehydratase / Q000378:metabolism; D000637:Transaminases / Q000378:metabolism; D014633:Valine / Q000494:pharmacology
D007532:Isoleucine; D006715:Homoserine Dehydrogenase; D000095:Acetolactate Synthase; D000637:Transaminases; D001222:Aspartate Kinase; D013913:Threonine Dehydratase; D007930:Leucine; D014633:Valine; D005947:Glucose; D005990:Glycerol